
Non-Statin Cholesterol-Lowering Drug Linked to Lower Cancer Risk
A study found that cholesterol absorption inhibitors are linked to a 31% lower risk of liver cancer, confirming similar benefits seen with statins, while other non-statin drugs showed no clear effect. Cholesterol absorption inhibitors, like statins, are …